BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-1.19%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$632M
AUM Growth
+$632M
(+5.4%)
Cap. Flow
+$56.5M
Cap. Flow
% of AUM
8.94%
Top 10 Holdings %
Top 10 Hldgs %
85.21%
Holding
32
New
4
Increased
11
Reduced
4
Closed
2
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$28.4M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$19.6M |
| 3 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.44M |
| 4 |
Cytokinetics
CYTK
|
$5.79M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$4.34M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$12.7M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
$10M |
| 3 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$3.82M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$1.44M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$1.43M |
Sector Composition
| 1 | Healthcare | 76.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $141M | 22.33% | 9,208,909 -94,094 | -1% | -$1.44M |
|
|
2
Ligand Pharmaceuticals
LGND
$3.15B
| $118M | 18.65% | 1,893,123 -203,293 | -10% | -$12.7M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $67.1M | 10.61% | 14,715,786 +6,228,859 | +73% | +$28.4M |
|
|
CCXI
4
DELISTED
ChemoCentryx, Inc.
CCXI
| $47.9M | 7.57% | 8,181,816 +385,300 | +5% | +$2.25M |
|
|
RCPT
5
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $38.8M | 6.13% | 910,600 +459,800 | +102% | +$19.6M |
|
|
CASC
6
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $31.9M | 5.05% | 9,858,278 +856,500 | +10% | +$2.78M |
|
7
Gyre Therapeutics
GYRE
$703M
| $30M | 4.75% | 6,655,128 +483,459 | +8% | +$2.18M |
|
|
FPRX
8
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $19.5M | 3.08% | 1,253,000 +117,000 | +10% | +$1.82M |
|
|
OMED
9
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $19.2M | 3.04% | 825,647 -164,131 | -17% | -$3.82M |
|
|
TBRA
10
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $17.7M | 2.8% | 2,607,091 +948,000 | +57% | +$6.44M |
|
|
QLTI
11
DELISTED
QLT Inc
QLTI
| $14.6M | 2.32% | 2,370,263 | – | – |
|
|
TRVN
12
DELISTED
Trevena, Inc.
TRVN
| $6.32M | 1% | 1,118,743 +768,743 | +220% | +$4.34M |
|
|
13
Cytokinetics
CYTK
$4.23B
| $6.3M | 1% | 1,317,000 +1,211,295 | +1,146% | +$5.79M |
|
|
ARQL
14
DELISTED
Arqule Inc
ARQL
| $4.84M | 0.77% | 3,124,887 +675,500 | +28% | +$1.05M |
|
15
Exelixis
EXEL
$10.1B
| $3.39M | 0.54% | +1,000,000 | New | +$3.39M |
|
16
Achieve Life Sciences
ACHV
$152M
| $3.22M | 0.51% | +862,069 | New | +$3.22M |
|
|
BLRX
17
BioLineRX
BLRX
$16.2M
| $3.12M | 0.49% | 1,501,000 +701,000 | +88% | +$1.46M |
|
|
KBIO
18
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $2.65M | 0.42% | +1,162,000 | New | +$2.65M |
|
|
ANTH
19
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.9M | 0.3% | 559,624 | – | – |
|
|
AKAO
20
DELISTED
Achaogen, Inc.
AKAO
| $1.75M | 0.28% | 125,000 | – | – |
|
21
uniQure
QURE
$896M
| $1.7M | 0.27% | +125,000 | New | +$1.7M |
|
|
PTN
22
DELISTED
Palatin Technologies
PTN
| $1.6M | 0.25% | 1,610,652 -1,199,172 | -43% | -$1.19M |
|
|
BIND
23
DELISTED
BIND THERAPEUTICS INC
BIND
| $1.53M | 0.24% | 116,000 | – | – |
|
|
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
| $1.49M | 0.24% | 184,999 | – | – |
|
|
SPHS
25
DELISTED
Sophiris Bio, Inc.
SPHS
| $1.34M | 0.21% | 600,000 | – | – |
|